ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

6 hedge funds and large institutions have $1.96M invested in Entero Therapeutics in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$181K
2
+$139K

Top Sellers

1
-$133K
2
-$40K
3
-$36K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$30K
5
BPA
Beacon Pointe Advisors
California
-$28K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$665K
2
$418K
3
$181K
4
$163K
5
$163K
6
$67K
7
$54K
8
$49K
9
$41K
10
$38K
11
$31K
12
$27K
13
$24K
14
$15K
15
$8K
16
$6K
17
$5K
18
$1K
19
–
20
–